Development of nicotinic receptor clusters and innervation accompanying the change in muscle phenotype in the mouse esophagus.
During development, the external muscle of the mouse esophagus undergoes a transdifferentiation from smooth to striated muscle (Patapoutian et al. [1995] Science 270:1818-1821). We now report on the development of the innervation accompanying the change in phenotype of the external muscle of the mouse esophagus. The phenotype of the muscle was monitored by using light and electron microscopy. Nicotinic acetylcholine receptors were localised by using a fluorescence conjugate of alpha-bungarotoxin, and neural elements were localised by using antisera to synaptophysin (a synaptic vesicle protein that was used to label all nerve terminals), the vesicular acetylcholine transporter (VAChT), calcitonin gene-related peptide (CGRP), nitric oxide synthase (NOS), and vasoactive intestinal peptide (VIP). CGRP and VAChT were co-localised in the terminals of vagal motoneurons that innervate the external muscle, and NOS and VIP were co-localised in intrinsic (enteric) neurons, which provide some terminals that are associated with motor endplates. Cells exhibiting striations were first observed in the outer layers of the most rostral regions of the esophagus of embryonic day 15 (E15) mice. Clusters of nicotinic acetylcholine receptors were also first observed at the rostral end of the esophagus of E15 mice, and developed in a rostrocaudal progression that coincided with the appearance of striations within the muscle cells. Synaptophysin-, VAChT- and NOS-immunoreactive nerve terminals were present within the external muscle prior to the formation of receptor clusters, and their appearance did not follow any apparent rostrocaudal sequence. Surprisingly, not all of the receptor clusters at E15 had synaptophysin- and VAChT-immunoreactive nerve terminals closely associated with them. However, from E18 on, almost all of the clusters had synaptophysin-immunoreactive nerve terminals in close association. At late embryonic and early postnatal stages, there was a rostrocaudal gradient in the proportion of receptor clusters having VAChT-immunoreactive nerve terminals associated with them. Nerve terminals associated with nicotinic receptor clusters did not show detectable CGRP-immunoreactivity until one to two weeks after the appearance of synaptophysin- and VAChT-immunoreactivity. The NOS-immunoreactive neurons did not show detectable VIP-immunoreactivity until three days after NOS could be detected. These results show that the appearance of clusters of nicotinic receptors in the external muscle of the esophagus coincides with the expression of a striated muscle phenotype, but not with the presence of ingrowing nerve terminals. However, many of the receptor clusters that were observed first were apparently uninnervated.
Sang
Q
Q
Department of Anatomy & Cell Biology, University of Melbourne, Parkville, VIC, Australia. q.sang@anatomy.unimelb.edu.au
Young
H M
HM
D000109:Acetylcholine / Q000378:metabolism; D000375:Aging / Q000502:physiology; D000818:Animals; D002038:Bungarotoxins / Q000378:metabolism; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis; D002352:Carrier Proteins / Q000032:analysis; D004622:Embryo, Mammalian; D004947:Esophagus / Q000166:cytology* / Q000294:innervation* / Q000378:metabolism; D005260:Female; D008297:Male; D026901:Membrane Transport Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D009045:Motor Endplate / Q000502:physiology / Q000648:ultrastructure; D009046:Motor Neurons / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D009130:Muscle, Smooth / Q000166:cytology* / Q000294:innervation* / Q000378:metabolism; D009411:Nerve Endings / Q000378:metabolism / Q000648:ultrastructure; D019001:Nitric Oxide Synthase / Q000032:analysis; D010641:Phenotype; D011978:Receptors, Nicotinic / Q000096:biosynthesis*; D013572:Synaptic Vesicles / Q000378:metabolism / Q000648:ultrastructure; D016708:Synaptophysin / Q000032:analysis; D014630:Vagus Nerve; D014660:Vasoactive Intestinal Peptide / Q000032:analysis; D050494:Vesicular Acetylcholine Transport Proteins; D033921:Vesicular Transport Proteins
D002038:Bungarotoxins; D002352:Carrier Proteins; D026901:Membrane Transport Proteins; D011978:Receptors, Nicotinic; C493460:Slc18a3 protein, mouse; D016708:Synaptophysin; D050494:Vesicular Acetylcholine Transport Proteins; D033921:Vesicular Transport Proteins; D014660:Vasoactive Intestinal Peptide; D019001:Nitric Oxide Synthase; D015740:Calcitonin Gene-Related Peptide; D000109:Acetylcholine